Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack | Zendy

Hooman Kamel | Zendy; S. Claiborne Johnston | Zendy; J. Donald Easton | Zendy; Anthony Kim | Zendy

Open Access

Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack

Author(s) -

Hooman Kamel,

S. Claiborne Johnston,

J. Donald Easton,

Anthony Kim

Publication year - 2012

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.641027

Subject(s) - medicine , dabigatran , atrial fibrillation , warfarin , stroke (engine) , quality adjusted life year , population , quality of life (healthcare) , cardiology , contraindication , cohort , anesthesia , cost effectiveness , mechanical engineering , risk analysis (engineering) , alternative medicine , nursing , environmental health , pathology , engineering

The cost-effectiveness of dabigatran for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack has not been directly assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research